Paris - Delayed Quote EUR
Nanobiotix S.A. (NANO.PA)
3.7450
+0.1450
+(4.02%)
As of 12:32:48 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-19,551
-19,551
-12,476
-37,103
-29,872
Investing Cash Flow
-955
-955
-349
138
-242
Financing Cash Flow
-5,135
-5,135
46,771
-5,651
-5,180
End Cash Position
49,737
49,737
75,283
41,388
83,921
Capital Expenditure
-848
-848
-337
-93
-233
Issuance of Capital Stock
0
0
60,154
0
0
Issuance of Debt
0
0
150
0
0
Repayment of Debt
-4,155
-4,155
-3,765
-4,735
-3,742
Free Cash Flow
-20,399
-20,399
-12,813
-37,196
-30,105
12/31/2021 - 10/29/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABVX.PA ABIVAX Société Anonyme
5.22
+0.97%
GNFT.PA Genfit S.A.
3.9200
+2.14%
OSE.PA OSE Immunotherapeutics SA
6.02
+1.18%
ADOC.PA Adocia SA
3.8600
+0.52%
IPH.PA Innate Pharma S.A.
1.9860
+1.33%
GNRO.PA GeNeuro SA
0.1160
+3.57%
DBV.PA DBV Technologies S.A.
1.5100
-8.04%
ALTME.PA TME Pharma N.V.
0.0829
+2.09%
SIGHT.PA GenSight Biologics S.A.
0.1986
+4.53%
ANNX.ST Annexin Pharmaceuticals AB (publ)
36.50
+2,159.41%